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Abstract
The Noyori-type (1S,2S)- and (1R,2R)-N-(para-tosyl)-1,2-diphenylethylene-1,2-di-
amine ligands complexed with ruthenium have been found to be effective catalysts
for the regiospecific transfer hydrogenation of 3-methoxy- and 3-benzyloxy-(Z)16-
hydroxymethylidene-13a-estra-1,3,5(10)-trien-17-ones to 3-methoxy- and 3-ben-
zyloxy-16-hydroxymethyl-13a-estra-1,3,5(10)-trien-17-one diastereomers. The
ratio of the diastereomers depends on the catalyst used. Further reduction of the
isolated products with NaBH4 in the presence of cerium(III) chloride (Luche
reduction conditions) yielded the corresponding diols. In contrast to the previous
preparation methods, this two-step simple hydrogenation/reduction protocol affor-
ded all four possible isomers in almost equal amounts.
Keywords Asymmetric catalysis  Transfer hydrogenation  Ruthenium  Steroid
Introduction
Hydroxymethylation of steroids at the C-16 position greatly affects their chemical
and biological properties and enhances their hydrophilic character. The traditional
chemical modification of steroids is rather complex. It requires multistep reactions
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combined with regioselective protection and deprotection, and usually can be
carried out only with abundant and readily available steroids [1]. On the other hand,
the preparation of steroid analogues with inverted configurations at the stereogenic
centers, on which the influence of such stereochemical change on physiological
properties can be evaluated, has received relatively little consideration [2, 3].
Previously, we have reported the preparation and determination of the structures of
the four possible isomers of 16-hydroxymethylestra-1,3,5(10)-trien-3,17-diol [4]
and their 3-methyl- and 3-benzyl ethers [5, 6]. In connection with our previous
investigations and the pharmacological results, we were interested in compounds
with an inverted configuration at C-13, that is, derivatives of 3-methoxy- and
3-benzyloxy-13a-estra-1,3,5(10)-trien-17-ones (1a, 1b) containing a cis junction of
C and D rings in the sterane skeleton.
Recently, we have described an extension of the C-16 hydroxymethylation to
3-methoxy- and 3-benzyloxy-13a-estra-1,3,5(10)-trien-17-one (1a, 1b). The treat-
ment of 1a and 1b with NaOMe and ethyl formate gave 3-methoxy- and
3-benzyloxy-16-hydroxymethyliden-13a-estra-1,3,5(10)-trien-17-ones (2a and 2b).
The resulting 16-hydroxymethylidene derivatives were reduced with KBH4 in
methanol forming two new chiral centers. However, only two of the possible four
isomers could be obtained in a 1:6 ratio. These compounds with trans configuration
(7a, 8a and 7b, 8b) could not be separated by flash chromatography on silica gel.
Therefore, selective acetylation of the primary hydroxyl group was carried out, and
the critical isomer pairs 7c, 8c and 7d, 8d could successfully be separated on a silica
gel column. The products after deacetylation by the Zemple´n method were
characterized as 3-methoxy- and 3-benzyloxy-16b-hydroxymethyl-13a-estra-
1,3,5(10)-trien-17a-ol (7a, 7b) as well as 3-methoxy- and 3-benzyloxy-16a-
hydroxymethyl-13a-estra-1,3,5(10)-trien-17b-ol (8a, 8b) [7, 8] (Scheme 1).
Our aim during the present investigations was to find a more convenient two-step
hydrogenation/reduction method to prepare the four possible isomers of 3-methoxy-
and 3-benzyloxy-16-hydroxymethyl-13a-estra-1,3,5(10)-trien-17-ol (5a, 6a, 7a, 8a
and 5b, 6b, 7b, 8b) by a well-controlled process. Recently, the regioselective
transfer hydrogenation of unsaturated carbonyl compounds has attracted a great deal
of attention because of the relatively benign nature of the reagents and mild reaction
conditions employed [9]. Ruthenium complexes are among the most often used
catalysts in the transfer hydrogenation of carbonyl compounds. The chiral
ruthenium complexes developed by Noyori and Ikariya bearing optically pure N-
(para-tosyl)-1,2-diphenylethylene-1,2-diamine ligands are highly active and selec-
tive in these reactions affording various chiral alcohols [10–13]. However, b-
dicarbonyl compounds or their isomeric c-ketoenol derivatives have been seldom
investigated [14–20] and outstanding results were obtained only in the hydrogena-
tion of aryl-substituted compounds [16, 19, 20]. Moreover, the transfer hydrogena-
tion of a,b-unsaturated carbonyl compounds often led to mixtures of reduced
products [21, 22]. In spite of these reports, we considered it useful to examine the
hydrogenation of 2a and 2b using the Noyori–Ikariya catalyst system. It must be
mentioned that the stereochemical outcome of these reactions could be influenced
by both the steroidal backbone and the chirality of the ligand. We stress out that no
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previous results on the reaction of steroid hydroxymethylidene ketones using such
catalysts have so far been disclosed.
Results and discussion
Here we report the transfer hydrogenation of 3-methoxy-16-hydroxymethyliden-
13a-estra-1,3,5(10)-trien-17-one (2a) and 3-benzyloxy-16-hydroxymethyliden-13a-
estra-1,3,5(10)-trien-17-one (2b) in the presence of Ru(S,S-Ts-DPEN)(para-
cymene)Cl (S,S-Ru) or the enantiomer Ru(R,R-Ts-DPEN)(para-cymene)Cl (R,R-
Ru). These were prepared in situ by reacting [RuCl2(g
6-para-cymene)]2 with the
corresponding chiral ligands (1S,2S)- or (1R,2R)-N-(para-toluenesulfonyl)-1,2-
diphenylethylene-1,2-diamine (Ts-DPEN) for 1 h in the presence of formic acid/
triethylamine 5/2 (molar ratio) complex used as hydrogen donor. Transfer
hydrogenations were carried out by adding 2a or 2b in N,N-dimethylformamide
solvent (DMF, typically 5 cm3) to the solution of the preformed catalyst in the
hydrogen donor. The resulting suspension was stirred at room temperature for 6 h.
During this time, the mixtures became clear solutions indicating that hydrogenations
were complete.
The analysis of products by TLC showed a mixture of 3-methoxy-16b-
hydroxymethyl-13a-estra-1,3,5(10)-trien-17-one (3a), 3-methoxy-16a-hydrox-
ymethyl-13a-estra-1,3,5(10)-trien-17-one (4a), 3-benzyloxy-16b-hydroxymethyl-
13a-estra-1,3,5(10)-trien-17-one (3b) and 3-benzyloxy-16a-hydroxymethyl-13a-
estra-1,3,5(10)-trien-17-one (4b), respectively. The mixture of the 3-methoxy (3a
Scheme 1 Reagents and conditions: (i) NaOMe, HCOOMe, anhydrous toluene; (ii) MeOH, NaBH4 (ratio
of 7:8 is 1:6)
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and 4a) and 3-benzyloxy (3b and 4b) diastereomers could be separated by flash
chromatography. The ratio of the diastereomers in the reaction mixture in presence
of S,S-Ru was nearly 1:4.5, whereas R,R-Ru provided a diastereomeric ratio of
1:2.5 (see Scheme 2 and Table 1). Accordingly, using both enantiomeric catalysts,
the major product was the same (4a or 4b), determined by the steroidal backbone.
However, the chirality of the catalyst influenced substantially the ratio of the
diastereomers.
Since the availability of the complete series of 3-methoxy- and 3-benzyloxy-16-
hydroxymethyl-13a-estra-1,3,5(10)-trien-17-ol isomers would permit a number of
interesting comparative examinations, we wished to prepare other isomers, which
contain functional groups with the configuration 16b,17b (5a and 5b) and 16a,17a
(6a and 6b). The reduction of the 17-ketone function of steroids in the 13b series
normally yields a 17b-hydroxy group (with a few exceptions [23]). This rule,
however, has not yet been established in the 13a series.
In the present study, we found that the reduction of 16b-hydroxymethyl-17-
ketone isomers (3a, 3b) in methanol with NaBH4 in the presence of cerium(III)
chloride (Luche reduction conditions [24, 25]) gave two compounds. The expected
16b,17b stereoisomers (5a, 5b) and 16b,17a isomers (7a, 7b) were obtained in
almost equal amounts. Similarly, under the same conditions the reduction of 16a-
hydroxymethyl-17-ketones (4a, 4b) yielded 16a,17a isomers (6a, 6b) and 16a,17b
isomers (8a, 8b) also obtained in equal amounts (Scheme 3). The cis arrangement of
5a, 5b and 6a, 6b was supported by the selective acetonide formation in reactions of
these isomers with acetone (5c, 6c and 5d, 6d) [26].
Conclusions
In conclusion, the above presented two-step transfer hydrogenation/reduction
procedure is an unprecedentedly convenient method for the preparation of all four
3-methoxy- and 3-benzyloxy-16-hydroxymethyl-13a-estra-1,3,5(10)-trien-17-ol
Scheme 2 Reagents and reaction conditions: (i) S,S-Ru or R,R-Ru, DMF, rt, 6 h
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stereoisomers from the corresponding 16-hydroxymethylidene-17-one derivatives.
Moreover, the application of this protocol in other series of such compound may
significantly simplify the synthesis of various steroid derivatives having tuned
biological properties.
Experimental
General procedures for the transfer hydrogenation, the Luche reduction and the
acetonide formation.
Table 1 Results of the catalytic transfer hydrogenations
Entry Substrate Chiral catalyst Products (%) 3/4 ratioa yield (%)a
1 2a S,S-Ru 3a (18.0) ? 4a (81.1) 1/4.50 99.1
2 2a R,R-Ru 3a (27.5) ? 4a (69.4) 1/2.52 96.9
3 2b S,S-Ru 3b (17.9) ? 4b (79.8) 1/4.45 97.7
4 2b R,R-Ru 3b (28.1) ? 4b (70.4) 1/2.50 98.5
Reaction conditions: 0.0062 mmol [RuCl2(g
6-para-cymene)]2, 0.0124 mmol chiral ligand, 1 cm
3
HCOOH/Et3N 5/2, 25 C, 1 h; addition of 6 mmol 2a or 2b (1.88 or 2.33 g) in 5 cm3 DMF; 25 C, 6 h
aYields and ratio were obtained after chromatographic separation
Scheme 3 Reagents and reaction conditions: (i) CeCl3, MeOH, NaBH4
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Transfer hydrogenation of 3-methoxy-16(Z)-hydroxymethylidene-13a-estra-
1,3,5(10)-trien-17-one (2a) and 3-benzyloxy-16(Z)-hydroxymethylidene-13a-
estra-1,3,5(10)-trien-17-one (2b) in the presence of TsDPEN in formic acid/
triethylamine 5/2 mixture
Catalyst S,S-Ru or R,R-Ru were prepared by magnetically stirring 0.0062 mmol
[RuCl2(g
6-para-cymene)]2 and 0.0124 mmol (1S,2S)- or (1R,2R)-N-(para-tosyl)-
1,2-diphenylethylene-1,2-diamine in 1 cm3 HCOOH/Et3N 5/2 mixture for 1 h in a
glass vial of 8 cm3. Following the formation of a yellow solution, compound 2a or
2b (1.88 or 2.33 g, 6 mmol) suspended in a 5 cm3 N,N-dimethylformamide was
introduced into the vial. The heterogeneous mixture was stirred at room temperature
under aerobic conditions for 6 h. The resulting clear solution was diluted with
CH2Cl2 (50 cm
3), washed with brine, water, dried over Na2SO4 and concentrated in
vacuo. The isomers were separated by flash-chromatography on silica gel with a
mixture of CH2Cl2/hexane.
Reduction of 16b-Hydroxymethyl-3-methoxy- and 16b-hydroxymethyl-3-
benzyloxy-13a-estra-1,3,5(10)-trien-17-one (3a, 3b) and 16a-hydroxymethyl-
3-methoxy- and 16a-hydroxymethyl-3-benzyloxy-13a-estra-1,3,5(10)-trien-
17-one (4a, 4b)
Cerium(III) chloride (anhydrous) (271.12 mg, 1.1 mmol) was added to a stirred
solution of 3a, 4a, 3b or 4b (1 mmol) in methanol (25 cm3). The mixture was
allowed to stir at room temperature until the chloride dissolved. Then NaBH4
(37.8 mg, 1.1 mmol) was added in small portions over 10–15 min. Vigorous
hydrogen gas evolution occurred and the progress of the reaction was monitored by
TLC. After completion (20–25 min) 5% aqueous HCl was added and the mixture
was extracted with EtOAc (2 9 25 cm3). The organic phase was washed with
saturated NaHCO3 solution, water, dried over Na2SO4 and evaporated in vacuo. The
residue obtained was then dissolved in CH2Cl2 and chromatographed on silica gel.
16b-Hydroxymethyl-3-methoxy- and 16b-hydroxymethyl-3-benzyloxy-13a-
estra-1,3,5(10)-trien-17b-ol, and 16a-hydroxymethyl-3-methoxy- and 16a-
hydroxymethyl-3-benzyloxy-13a-estra-1,3,5(10)-trien-17a-ol acetonides
(5c, 5d and 6c, 6d)
Compound 5a, 5b, 6a or 6b (0.5 mmol) was dissolved in acetone (3 cm3) and a
catalytic amount of p-toluenesulfonic acid was added. The reaction mixture was
treated at reflux temperature for 30 min, neutralized with morpholine, diluted with
CH2Cl2 (10 cm
3) and then washed with water. The organic layer was dried over
Na2SO4 and evaporated in vacuo. The crude product was crystallized from
methanol.
Analytical data of the isolated, purified materials are attached in the supporting
information.
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